Catalyst Wire Dossier Catalyst Wire Dossier

BIIB093

· Remedy Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BIIB093, covering 2023-12-20 to 2023-12-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of BIIB093 in Participants With Brain Contusion [Phase 2]

See pricing